An independent tribunal has suspended American tennis player Jessica Eudovic for a period of two years for breaching tennis’ anti-doping rules.

19-year-old Eudovic has been provisionally suspended since 21 November 2025, after testing positive for the prohibited substance clostebol at a World Tennis Tour event in Santa Tecla, El Salvador, on 1 October 2025.

Clostebol is prohibited at all times under the Tennis Anti-Doping Programme (TADP).

Eudovic, who reached a career-high World Tennis (formerly ITF) singles ranking of 1104 in October 2025, sought to challenge the proposed suspension, and so case was referred to an independent tribunal.

Following a two-day hearing in October 2026, the tribunal found that while Eudovic did not establish how clostebol entered her system, the breach was not intentional.

In reaching its decision, the tribunal considered the scientific evidence, including the very low level of clostebol detected in Eudovic’s sample, the circumstances of the case, and Eudovic’s evidence.

As Eudovic was unable to establish how the prohibited substance entered her system, despite accessing the ITIA’s support fund for product testing, the tribunal could not consider a further reduction of the sanction. Eudovic was therefore suspended for two years.

Time served under provisional suspension is credited against the sanction. As such, Eudovic’s suspension ends on 20 November 2027. Eudovic’s results from the event in Santa Tecla are also disqualified, with the associated ranking points and prize money forfeited.

While suspended, Eudovic is not allowed to play in, coach at, or attend any events organised or sanctioned by World Tennis, WTA, ATP, the Grand Slams, or any national association.

To read the tribunal’s decision in full, click here.

Ends

Published 19 November 2026 14:00